ATE450602T1 - Stemzelldifferenzierung induzierende promoter - Google Patents

Stemzelldifferenzierung induzierende promoter

Info

Publication number
ATE450602T1
ATE450602T1 AT01972471T AT01972471T ATE450602T1 AT E450602 T1 ATE450602 T1 AT E450602T1 AT 01972471 T AT01972471 T AT 01972471T AT 01972471 T AT01972471 T AT 01972471T AT E450602 T1 ATE450602 T1 AT E450602T1
Authority
AT
Austria
Prior art keywords
diseases
cell differentiation
cells
stem cell
stem
Prior art date
Application number
AT01972471T
Other languages
English (en)
Inventor
Bang Luu
Eliane Mohier
Masashi Yamada
Yukie Suma
Hiroto Suzuki
Original Assignee
Meiji Dairies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2000304746A external-priority patent/JP2002068973A/ja
Application filed by Meiji Dairies Corp filed Critical Meiji Dairies Corp
Application granted granted Critical
Publication of ATE450602T1 publication Critical patent/ATE450602T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/713—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups a keto group being part of a six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/06—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms
    • C07C403/08—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms by hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/511—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/57—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
    • C07C45/59—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT01972471T 2000-10-04 2001-09-19 Stemzelldifferenzierung induzierende promoter ATE450602T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000304746A JP2002068973A (ja) 2000-06-16 2000-10-04 幹細胞分化誘導促進剤
PCT/JP2001/008136 WO2002029014A2 (en) 2000-10-04 2001-09-19 Stem cell differentiation-inducing promoter

Publications (1)

Publication Number Publication Date
ATE450602T1 true ATE450602T1 (de) 2009-12-15

Family

ID=18785739

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01972471T ATE450602T1 (de) 2000-10-04 2001-09-19 Stemzelldifferenzierung induzierende promoter

Country Status (6)

Country Link
US (1) US20040115810A1 (de)
EP (1) EP1322748B1 (de)
AT (1) ATE450602T1 (de)
CA (1) CA2424207C (de)
DE (1) DE60140685D1 (de)
WO (1) WO2002029014A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4861560B2 (ja) * 2001-02-19 2012-01-25 株式会社明治 糖尿病合併症治療剤
EP1608612B1 (de) * 2003-03-28 2008-02-27 Meiji Dairies Corporation Verfahren zur herstellung von langkettigen alkoholen
US20080125495A1 (en) * 2004-11-25 2008-05-29 Meiji Dairies Corporation Ameliorant For Renal Insufficiency
EP2521587B1 (de) 2010-01-08 2020-04-08 Wake Forest University Health Sciences Freisetzungssystem
EP2683328B1 (de) 2011-03-07 2017-11-08 Wake Forest University Health Sciences Freisetzungssystem
JP6807396B2 (ja) 2016-01-22 2021-01-06 大鵬薬品工業株式会社 高純度シクロへキセノン長鎖アルコールの調製方法
CN107032975B (zh) * 2016-02-03 2022-06-28 大鹏药品工业株式会社 一种高纯度环己烯酮长链醇的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2299308C (en) * 1997-08-13 2008-03-25 Meiji Milk Products Co., Ltd. Cyclohexenone long-chain alcohol and medicament containing same

Also Published As

Publication number Publication date
WO2002029014A3 (en) 2002-12-19
US20040115810A1 (en) 2004-06-17
WO2002029014A2 (en) 2002-04-11
CA2424207C (en) 2013-03-26
EP1322748A2 (de) 2003-07-02
EP1322748B1 (de) 2009-12-02
DE60140685D1 (de) 2010-01-14
CA2424207A1 (en) 2002-04-11

Similar Documents

Publication Publication Date Title
CA1126158A (en) Cosmetic composition containing kojic acid ester
KR101740097B1 (ko) 에델바이스 식물 세포 배양 추출물을 함유한 항염 및 항노화 효과를 지닌 피부 외용제 조성물 및 그 제조방법
EP1281398A4 (de) Dermale zusammenstellungen die als wirkstoff coenzym q enthalten
AU2003222049B2 (en) Prostaglandin F2 alpha analogs in combination with antimicrobials for treating glaucoma
ATE223215T1 (de) Inhibitoren der fettsäuresynthese als antimikrobielle mittel
BR0209320A (pt) ésteres de uridina farmaceuticamente ativos
RU2482116C2 (ru) Новые 4-(гетероциклоалкил)бензол-1,3-диольные соединения в качестве ингибиторов тирозиназ, способ их получения и их применение в лечении человека, а также в косметических средствах
TW200602031A (en) Antiinflammatory and pain-relieving agent for external, use
ATE450602T1 (de) Stemzelldifferenzierung induzierende promoter
EP3722414A2 (de) Mediumzusammensetzung zur zellproliferation, hautregeneration und faltenverbesserung mit aus vogeleiern isolierten konditionierten medium pluripotenten stammzellen, neuronalen stammzellen oder embryonalen fibroblasten als wirkstoff
JP2007161591A (ja) メラニン産生阻害皮膚外用剤
DE60216239T8 (de) Verwendung von Cyclohexenon-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von Dysurie
US9463338B2 (en) Derivatives of the sinapinic acid
KR20150067130A (ko) 조직 보존액 및 조직 보존 방법
DE50211978D1 (de) Stabilisierung oxidations- und/oder uv-empfindlicher wirkstoffe
KR101693923B1 (ko) 잘피 식물 세포 배양 추출물을 함유한 항염 및 항노화 효과를 지닌 피부 외용제 조성물 및 그 제조방법
DE60238666D1 (de) Cyclohexenon derivate zur behandlung der diabetischen neuropathie
RU2539589C2 (ru) Серосодержащие производные резорцина, способ их получения и косметическое применение
KR20090052096A (ko) 이끼 추출물 또는 그 유효 성분인 뎁시돈 또는 뎁시돈유도체를 함유하는 항노화 피부 외용제 조성물
ATE144768T1 (de) Octahydronaphthalenoxim derivate für die inhibierung der cholesterin biosynthese, ihre herstellung und verwendung
Graf et al. Lipophilic prodrugs of amino acids and vitamin E as osmolytes for the compensation of hyperosmotic stress in human keratinocytes
AU2001260695A1 (en) Malto-oligosaccharide derivatives and use thereof
US20190240512A1 (en) Cosmetic treatment method for the skin
WO2002044403A3 (en) Markers for testing analogs of vitamin d and therapeutical uses
KR20250152146A (ko) N-벤질-n-메틸데칸-1-아민 또는 그 유도체를 유효성분으로 항산화, 미백, 주름개선을 통한 광노화 억제 효능

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties